Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar 18;146(6):263-6.
doi: 10.1016/j.medcli.2015.11.008. Epub 2015 Dec 23.

[Nodular regenerative hyperplasia associated with common variable immunodeficiency and other comorbidities]

[Article in Spanish]
Affiliations

[Nodular regenerative hyperplasia associated with common variable immunodeficiency and other comorbidities]

[Article in Spanish]
Rafael León et al. Med Clin (Barc). .

Abstract

Background and objective: Currently, there are not many data on the evolution of nodular regenerative hyperplasia (NRH) associated or not with underlying diseases and in particular that associated with common variable inmunodeficiency (CVID). Twenty cases of NRH are presented, and the differences between the cases associated with CVID and those related to other diseases are analysed.

Methods: Retrospective and descriptive study over a period of 14 years.

Results: Twelve out of the 20 patients were men; the median age was 51 years. CVID was the main illness associated with NRH. In patients with CVID and NRH, gastrointestinal haemorrhage was more common, all the patients had high gamma glutamyl transferase and alkaline phosphatase and none had altered albumin and bilirubin levels compared to the patients without CVID. On follow-up, 50% of patients with CVID (2/4) had died compared to 33.3% (5/15) without CVID.

Conclusions: NRH in patients with CVID seems to have more biochemical data of anicteric cholestasis and portal hypertension and could be associated with lower survival.

Keywords: Common variable immunodeficiency; Hiperplasia nodular regenerativa; Hipertensión portal; Inmunodeficiencia común variable; Nodular regenerative hyperplasia; Portal hypertension.

PubMed Disclaimer

Similar articles

Cited by

LinkOut - more resources